Effect of hypernatremia on injury caused by energy deficiency: Role of T-type Ca2+ channel

American Journal of Physiology - Cell Physiology

Volumn 299, Issue 2, 2010, Pages

  Pastukh, Viktor ^a   Chen, Hairu ^a   Wu, Songwei ^a   Jong, Chian Ju ^a   Alexeyev, Mikhail ^a   Schaffer, Stephen W ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Calcium homeostasis; Diphenylhydantoin; Neonatal cardiomyocytes; Reactive oxygen species; Ribonucleic acid interference

Indexed keywords

AMOBARBITAL; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL CAV3.1; CALCIUM CHANNEL T TYPE; DEOXYGLUCOSE; PHENYTOIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; SODIUM; UNCLASSIFIED DRUG; CA(V)3.1 PROTEIN, RAT;

ARTICLE; BIOACCUMULATION; CALCIUM HOMEOSTASIS; CELL DAMAGE; CELL DEATH; CELL ISOLATION; CELL PROTECTION; CELL STRESS; CONTROLLED STUDY; DOWN REGULATION; ELECTRON TRANSPORT; ENERGY DEFICIENCY; ENERGY METABOLISM; ENZYME ACTIVATION; HEART MUSCLE CELL; HYPERNATREMIA; HYPEROSMOTIC STRESS; INCUBATION TIME; METABOLIC DISORDER; METABOLIC INHIBITION; MOLECULAR DYNAMICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; METABOLISM; NEWBORN; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; CALCIUM CHANNELS, T-TYPE; CELL DEATH; CELLS, CULTURED; DOWN-REGULATION; ELECTRON TRANSPORT; ENERGY METABOLISM; HYPERNATREMIA; MYOCYTES, CARDIAC; RATS; RATS, WISTAR;

EID: 77955882818     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00362.2009     Document Type: Article

References (37)

1. Allo SN, Bagby L, Schaffer SW. Taurine depletion, a novel mechanism for cardioprotection from regional ischemia. Am J Physiol Heart Circ Physiol 273: H1956-H1961, 1997.
2. Bhardwaj A, Harukuni I, Murphy SJ, Alkayed NJ, Crain BJ, Koehler RC, Hurn PD, Traystman RJ. Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke 31: 1694-1701, 2000.
3. Chan PM, Lim L, Manser E. PAK is regulated by PI3K, PIX, CDC42 and PP2alpha and mediates focal adhesion turnover in the hyperosmotic stress-induced p38 pathway. J Biol Chem 283: 24949-61, 2008.
4. Costa ADT, Pierre SV, Cohen MV, Downey JM, Garlid KD. cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res 77: 344-352, 2008.
5. 2+ channels by hypoxia and glutathione. Pflügers Arch 441: 181-188, 2000.
6. 2+ channel during fetal and postnatal rat heart development. J Mol Cell Cardiol 34: 533-546, 2002.
7. Garcia-Dorado D, Oliveras J. Myocardial Oedema: a preventable cause of reperfusion injury? Cardiovasc Res 27: 1555-1563, 1993.
8. Griffiths EJ, Bell CJ, Balaska D, Rutter GA. Mitochondial calcium: role in the normal and ischaemic/reperfused myocardium. In: Mitochondria: the Dynamic Organelle, edited by Schaffer SW, Suleiman MS. New York: Springer Science & Business Media, 2007, p. 197-220.
9. Halestrap AP. What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46: 821-831, 2009.
10. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 116: 173-191, 2007.
11. + antiport is mediated by protein kinase C. J Physiol 536: 703-715, 2001.
12. Hoffmann EK, Lambert IH, Pedersen SF. Physiology of cell volume regulation in vertebrates. Physiol Rev 89: 193-277, 2009.
13. 2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res 46: 442-449, 2000.
14. + exchange: structure, regulation and its role in heart disease. Circ Res 85: 777-786, 1999.
15. Lacinova L. Pharmacology of recombinant low-voltage activated calcium channels. Curr Drug Targets CNS Neurol Disord 3: 105-11, 2004.
16. Lee DS, Goodman S, Dean DM, Lenis J, Ma P, Gervais PB, Langer A. Randomized comparisonof T-type versus L-type calcium channel blockade on exercise duration in stable angina: results of the Posicor reduction of ischemia during exercise (PRIDE) trial. Am Heart J 144: 60-67, 2002.
17. Liu J, Tsang S, Wong TM. Testosterone is required for delayed cardioprotection and enhanced heart shock protein 70 expression induced by preconditioning. Endocrinology 147: 4569-4577, 2006.
18. Lo HM, Kloner RA, Braunwald E. Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment. Am J Cardiol 56: 672-677, 1985.
19. Lory P, Chemin J. Towards the discovery of novel T-type calcium channel blockers. Expert Opin Ther Targets 11: 717-22, 2007.
20. Muller CA, Opie LH, McCarthy J, Hofmann D, Pineda CA, Peisach M. Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia. J Am Coll Cardiol 32: 268-274, 1998.
21. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88: 581-609, 2008.
22. Pastukh V, Ricci V, Solodushko V, Mozaffari M, Schaffer SW. Contribution of the PI 3-kinase/Akt survival pathway toward osmotic preconditioning. Mol Cell Biochem 269: 59-67, 2005.
23. Pastukh V, Shokolenko IN, Wilson GL, Alexeyev MF. Mutations in the passenger polypeptide can affect its partitioning between mitochondria and cytoplasm: mutations can impair the mitochondrial import of DsRed. Mol Biol Rep 35: 215-223, 2008.
24. Pastukh V, Wu S, Ricci C, Mozaffari M, Schaffer S. Reversal of hyperglycemic preconditioning by angiotensin II: role of calcium transport. Am J Physiol Heart Circ Physiol 288: H1965-H1975, 2005.
25. Penna C, Mancardi D, Rastaldo R, Pagliaro P. Cardioprotection: a radical view; free radicals in pre and postconditioning. Biochim Biophys Acta 1787: 781-793, 2009.
26. Perez-Reyes E. Molecular physiology of low-voltage activated T-type calcium channels. Physiol Rev 83: 117-161, 2003.
27. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 38: 291-300, 1998.
28. Ricci C, Jong CJ, Schaffer SW. Proapoptotic and antiapoptotic effects of hyperglycemia: role of insulin signaling. Can J Physiol Pharmacol 86: 166-172, 2008.
29. Ricci C, Pastukh V, Leonard J, Turrens J, Wilson G, Schaffer D, Schaffer SW. Mitochondrial DNA damage triggers mitochondrial superoxide generation and apoptosis. Am J Physiol Cell Physiol 294: C413-C422, 2008.
30. Rodrigo GC, Samani NJ. Ischemic preconditioning of the whole heart confers protection on subsequently isolated ventricular myocytes. Am J Physiol Heart Circ Physiol 294: H524-H531, 2008.
31. Roux S, Buhler M, Clozel JP. Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs; comparison with amlodipine. J Cardiovasc Pharmacol 27: 132-139, 1996.
32. + exchange during metabolic inhibition in guinea pig ventricular myocytes. Clin Sci 101: 243-251, 2001.
33. Schaffer SW, Ballard Croft C, Solodushko V. Cardioprotective effect of chronic hyperglycemia: effect of hypoxia-induced apoptosis and necrosis. Am J Physiol Heart Circ Physiol 278: H1948-H1954, 2000.
34. Schaffer SW, Solodushko V, Kakhniashvili D. Beneficial effect of taurine depletion on osmotic sodium and calcium loading during chemical hypoxia. Am J Physiol Cell Physiol 282: C1113-C1120, 2002.
35. Steenbergen C, Hill ML, Jennings RB. Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Circ Res 57: 864-875, 1985.
36. 2+ efflux in rat ventricular myocytes. Biophys J 96: 4941-4950, 2009.
37. Zhuang S, Hirai SI, Ohno S. Hyperosmolality induces activation of cPKC and nPKC, a requirement for ERK1/2 activation in NIH/3T3 cells. Am J Physiol Cell Physiol 278: C102-C109, 2000.